Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 34, 2021 - Issue 10
Submit an article Journal homepage
234
Views
3
CrossRef citations to date
0
Altmetric
Short Report

Maternal and neonatal serum expression of the vascular growth factors in hyperglycemia in pregnancy

Filip A. Dabrowskia 1st Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Medical University of Warsaw, Warsaw, PolandORCID Iconhttps://orcid.org/0000-0002-8557-4091View further author information
ORCID Icon,
Michal Lipaa 1st Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Medical University of Warsaw, Warsaw, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1289-0245View further author information
ORCID Icon,
Zbigniew Bartoszewiczb Department of Endocrinology and Internal Medicine, 1st Faculty of Medicine, Medical University of Warsaw, Warsaw, PolandView further author information
,
Miroslaw Wielgosa 1st Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Medical University of Warsaw, Warsaw, PolandORCID Iconhttps://orcid.org/0000-0003-2581-3668View further author information
ORCID Icon &
Dorota A. Bomba-Opona 1st Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Medical University of Warsaw, Warsaw, PolandView further author information
Pages 1673-1678 | Received 28 May 2019, Accepted 01 Jul 2019, Published online: 15 Jul 2019

References

  • Zhou J, Ni X, Huang X, et al. Potential role of hyperglycemia in fetoplacental endothelial dysfunction in gestational diabetes mellitus. Cell Physiol Biochem. 2016;39:1317–1328.
  • Radaelli T, Varastehpour A, Catalano P, et al. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52:2951–2958.
  • Gauster M, Desoye G, Tötsch M, et al. The placenta and gestational diabetes mellitus. Curr Diab Rep. 2012;12:16–23.
  • Helske S, Vuorela P, Carpén O, et al. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 2001;7:205–210.
  • Demir R, Kayisli UA, Cayli S, et al. Sequential steps during vasculogenesis and angiogenesis in the very early human placenta. Placenta. 2006;27:535–539.
  • Stanirowski PJ, Szukiewicz D, Pazura-Turowska M, et al. Placental expression of glucose transporter proteins in pregnancies complicated by gestational and pregestational diabetes mellitus. Can J Diabetes. 2018;42:209–217.
  • Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21:103–113.
  • Björk O, Persson B. Placental changes in relation to the degree of metabolic control in diabetes mellitus. Placenta. 1982;3:367–378.
  • Schaarschmidt W, Rana S, Stepan H. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med. 2013;41:511–516.
  • Nucci M, Poon LC, Demirdjian G, et al. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11–13 weeks’ gestation in normal and pathological pregnancies. Fetal Diagn Ther. 2014;36:106–116.
  • Kosiński P, Samaha RB, Bomba-Opoń DA, et al. Reference values for placental growth factor (PlGF) concentration and uterine artery Doppler pulsatility index (PI) at 11–13(+6) weeks of gestation in the Polish population. Ginekol Pol. 2014;85:488–493.
  • Mosimann B, Amylidi S, Risch L, et al. First-trimester placental growth factor in screening for gestational diabetes. Fetal Diagn Ther. 2015;39:287–291.
  • Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30 (Suppl A):S38–S42.
  • Dragan I, Georgiou T, Prodan N, et al. Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30–37 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;49:73–77.
  • Eleftheriades M, Papastefanou I, Lambrinoudaki I, et al. Elevated placental growth factor concentrations at 11–14 weeks of gestation to predict gestational diabetes mellitus. Metabolism. 2014;63:1419–1425.
  • Meng Q, Shao L, Luo X, et al. Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies. Reprod Biol Endocrinol. 2016;14:61.
  • Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 2002;51:159–167.
  • Yang Z, Mo X, Gong Q, et al. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose. Apoptosis. 2008;13:1331–1343.
  • Fox H. Pathology of the placenta in maternal diabetes mellitus. Obstet Gynecol. 1969;34:792–798.
  • Asmussen I. Ultrastructure of the villi and fetal capillaries of the placentas delivered by non-smoking diabetic women (White group D). Acta Pathol Microbiol Immunol Scand A. 1982;90:95–101.
  • Stenczer B, Molvarec A, Veresh Z, et al. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia. Acta Obstet Gynecol Scand. 2011;90:1291–1295.
  • Teichert-Kuliszewska K, Maisonpierre PC, Jones N, et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res. 2001;49:659–670.
  • Lekva T, Lyle R, Roland MCP, et al. Gene expression in term placentas is regulated more by spinal or epidural anesthesia than by late-onset preeclampsia or gestational diabetes mellitus. Sci Rep. 2016;6:29715.
  • Loegl J, Nussbaumer E, Cvitic S, et al. GDM alters paracrine regulation of feto-placental angiogenesis via the trophoblast. Lab Invest. 2017;97:409–418.
  • Warren LL. Acute hypoxemic respiratory failure and ARDS, Murray and Nadel’s textbook of respiratory medicine. 6th ed. Vol. 100. Elsevier; 2016.
  • Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12:1286–1293.
  • Thurston G, Daly C. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb Perspect Med. 2012;2:a006550.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.